glp-1 telehealth crackdown news today Foundayo Takes Off, & FDA Warning! Major insurance changes are coming
Description
GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)
Oxyntomodulin Surprisingly, given that glucagon is not a physiological DPP-4 substrate (37, 38), there is some evidence that the C-terminally extended peptide, oxyntomodulin might be
The goals are to reduce fracture risk, minimize ongoing bone loss, prevent disability, and manage pain
If you are pregnant or breastfeeding, do not take Zepbound (Tirzepatide) because it is not known if it will harm your unborn baby or pass into your breast milk
Most Hashimoto's patients on microdosing protocols begin noticing improvements in energy and appetite regulation within 4-6 weeks
Researchers analyzed 59,293 unique public Facebook posts discussing GLP-1 RA medications
